NCT06317077View on ClinicalTrials.gov

Investigation of the Accordance Between Event Detection of prismaLINE Devices and Polysomnography Using Full Face Masks

NANot yet recruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

May 15, 2024

Primary Completion Date

May 15, 2025

Study Completion Date

May 15, 2025

Conditions
Sleep Apnea Syndromes
Interventions
OTHER

PAP therapy setting

Subtherapeutic phases during titration to provoke breathing events after reaching the pressure level with which the breathing events are sufficiently treated

OTHER

exclusive use of Löwenstein Medical full face masks

Use of a Löwenstein Medical full face mask as a requirement for participation in the clinical investigation

Trial Locations (1)

42699

Krankenhaus Bethanien, Solingen

All Listed Sponsors
lead

Löwenstein Medical Technology GmbH & Co. KG

INDUSTRY

NCT06317077 - Investigation of the Accordance Between Event Detection of prismaLINE Devices and Polysomnography Using Full Face Masks | Biotech Hunter | Biotech Hunter